P/E ratio for Medibank (MPL.AX)
P/E ratio at the end of 2022: 33.5
According to Medibank's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.0876. At the end of 2022 the company had a P/E ratio of 33.5.
P/E ratio history for Medibank from 2015 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 33.5 | 27.6% |
| 2021 | 26.3 | -29.95% |
| 2020 | 37.5 | 26.47% |
| 2019 | 29.7 | 21.79% |
| 2018 | 24.4 | 7.46% |
| 2017 | 22.7 | -11.54% |
| 2016 | 25.6 | 1.75% |
| 2015 | 25.2 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.